AUSTIN, TX (November 8, 2004) – Emerson Process Management and GE Healthcare announced last week a global marketing agreement to provide solutions for protein purification – a critical operation in manufacturing of biotech medicines.
WASHINGTON, DC (November 8, 2004) – The Food & Drug Administration last week warned consumers not to purchase or consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.
NEWTON, TX (November 2, 2004) – Mobile Medical & Command CentersInc. has begun marketing specialized mobile command centers for use by municipalities during times of crisis, such as when traditional posts have been compromised or destroyed.
WASHINGTON, DC (November 2, 2004) – The Food & Drug Administration (FDA) is planning to split the
Washington, DC (November 2, 2004) -- The Food & Drug Administration (FDA) has named Dr. Edward Otto as director of the Office of Cellular, Tissue & Gene Therapies within the agency's Center for Biologic Evaluation & Research (CBER). The appointment is effective November 14. Dr.
BOSTON, MA (November 2, 2004) – The Bristol-Myers Squibb Foundation and the China Foundation for
WILMINGTON, DE (November 2, 2004) – DuPont this week announced the addition of Dr. Marcelo Carvalho de Andrade to its external Biotechnology Advisory Panel. Dr.
NEW YORK, NY (October 25, 2004) – Sales of products incorporating emergingnanotechnology will rise from less than 0.1 percent of global manufacturing outputtoday to 15 percent in 2014, totaling $2.6 trillion, according to a new report fromLux Research entitled “Sizing Nanotechnology's Value Chain.
ABBOTT PARK, IL (October 25, 2004) – Abbott announced the acquisition of Spine Next, S.A., of
WASHINGTON, DC (October 25, 2004) – Sanofi-Aventis plans to build a more than $1 billion generic business to help enhance its ability to contract with managed care, The Pink Sheet newsletter reported this week.
WALTHAM, MA (October 25, 2004) – Decision Resources, Inc., a research and advisory firm focusing
BOTHELL, WA (October 25, 2004) – Nastech Pharmaceutical Co. Inc. has entered into an exclusive license and supply agreement with Par Pharmaceutical, Inc. for United States distribution and marketing of Nastech’s calcitonin-salmon nasal spray for the treatment of osteoporosis.
Drug Development Services Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries.
Industrial-Strength Vacuums Heavy-duty Nilfisk and CFM vacuum cleaners efficiently collect everything from food scraps to pharmaceutical powders to bulk materials.